Session » Health Services Research, Quality Measures and Quality of Care - Pediatrics, Immunization and Choosing Wisely

Meeting: 2013 ACR/ARHP Annual Meeting

Abstract Number: 844

Level and Determinants Of Health Related Quality Of Life In Childhood-Onset Systemic Lupus Erythematosus

Abstract Number: 845

Improving Pneumococcal Vaccination Rate In The Pediatric Rheumatology Clinic

Abstract Number: 846

Applying Choosing Wisely: Identifying Inefficiencies Of Antinuclear Antibody Subserology Testing In a Safety Net Health System

Abstract Number: 847

Do Rheumatologists (and Other Specialists) Practice What We Preach? A Study Of Serology Ordering Patterns With Attention To Subserologies When The Antinuclear Antibody By Enzyme Linked Immunosorbent Assay Is Negative; And The Clinical Significance Of These Positive Subserology Results

Abstract Number: 848

Human Papillomavirus Vaccine Uptake Among Children and Young Adults With Autoimmune Diseases

Abstract Number: 849

Reasons For Failure To Obtain Influenza and Pneumococcal Vaccines Among Immunosuppressed Individuals With Systemic Lupus Erythematosus

« View all sessions from this meeting

All abstracts accepted to ACR Convergence are under embargo once the ACR has notified presenters of their abstract’s acceptance, and cannot be presented at other meetings after this time. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. Academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part a scientific presentation or presentation of additional new information that will be available at the time of the meeting) is under embargo until November 7 at 10:00 AM ET. Journalists with access to embargoed information also cannot release articles before this time.

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Permissions and Reprints

For information about abstract permissions and reprints, see ACR Convergence permissions and reprint policies.